Author

Nicolas Landrein

Centre National de la Recherche ScientifiqueORCID 0000-0001-8875-4242Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Harald WodrichiD· 2 shared Anastasiia V. TymchenkoiD· 1 shared Ann E. TollefsoniD· 1 shared Anna Cline-SmithiD· 1 shared Benoı̂t Roger· 1 shared Charlotte Quentin-FroignantiD· 1 shared Denis DacheuxiD· 1 shared Derrick Roy RobinsoniD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Harald WodrichORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintJul 1, 2026

A distinct signature of interferon-stimulated genes linked to cross-protection against secondary viral infections in primary bronchial epithelial cells

Anastasiia V. Tymchenko, Morgane Fierville, Pauline Estèves…·Thomas Trian

DOI 10.64898/2026.06.30.735481

humanbulk RNA-seq

𝕏 PostBluesky

MicrobiologybioRxivPreprintMar 23, 2025

Flagellar pocket collar biogenesis: Cytoskeletal organization and novel structures in a unicellular parasite

Marie Zelená, Elina Casas, Lambert Chloé…·Mélanie Bonhivers

This study uses ultrastructure expansion microscopy to investigate FPC biogenesis in Trypanosoma brucei, identifying novel structures and tracking key proteins during cell division.

DOI 10.1101/2025.03.23.644790

electronic health recordsexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintFeb 20, 2025

LAVR-289, a New Orally Bioavailable Inhibitor of Adenovirus Replication in vitro and in vivo.

Charlotte Quentin-Froignant, Ann E. Tollefson, Anna Cline-Smith…·Franck Gallardo

This study evaluates LAVR-289, an acyclonucleoside phosphonate, showing potent antiviral activity against adenovirus in vitro and in vivo, with 100% survival in immunocompromised hamsters.

DOI 10.1101/2025.02.20.639236

mouseexperimental assay

𝕏 PostBluesky